Nash is the largest cause for a liver transplants and liver cancer s in the coming decade. We've worked with gilead to allow us to create cell types froma people, like normal people who are sick with nash. Once you know how to work with liver cells, then you could apply this to a whole range of other liver diseases. The other area that we've made a significant investment in is diseases of the central nervous system. This is an area where i think there is tremendous potential,. because has been a much greater understanding of the genetics of those diseases....